276 related articles for article (PubMed ID: 22243442)
1. Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control study.
Hallas J; Christensen R; Andersen M; Friis S; Bjerrum L
Br J Clin Pharmacol; 2012 Jul; 74(1):180-8. PubMed ID: 22243442
[TBL] [Abstract][Full Text] [Related]
2. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
3. The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer.
Mandilaras V; Bouganim N; Yin H; Asselah J; Azoulay L
Br J Cancer; 2017 Jan; 116(1):103-108. PubMed ID: 27846200
[TBL] [Abstract][Full Text] [Related]
4. Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study.
Mansfield KE; Nitsch D; Smeeth L; Bhaskaran K; Tomlinson LA
BMJ Open; 2016 Dec; 6(12):e012690. PubMed ID: 28003286
[TBL] [Abstract][Full Text] [Related]
5. Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts.
Cardwell CR; Mc Menamin ÚC; Hicks BM; Hughes C; Cantwell MM; Murray LJ
BMC Med; 2014 Feb; 12():28. PubMed ID: 24521426
[TBL] [Abstract][Full Text] [Related]
6. Long-term use of angiotensin receptor blockers and the risk of cancer.
Azoulay L; Assimes TL; Yin H; Bartels DB; Schiffrin EL; Suissa S
PLoS One; 2012; 7(12):e50893. PubMed ID: 23251399
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies.
Kunutsor SK; Blom AW; Whitehouse MR; Kehoe PG; Laukkanen JA
Eur J Epidemiol; 2017 Nov; 32(11):947-959. PubMed ID: 28752198
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
Bangalore S; Kumar S; Kjeldsen SE; Makani H; Grossman E; Wetterslev J; Gupta AK; Sever PS; Gluud C; Messerli FH
Lancet Oncol; 2011 Jan; 12(1):65-82. PubMed ID: 21123111
[TBL] [Abstract][Full Text] [Related]
9. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
Copland E; Canoy D; Nazarzadeh M; Bidel Z; Ramakrishnan R; Woodward M; Chalmers J; Teo KK; Pepine CJ; Davis BR; Kjeldsen S; Sundström J; Rahimi K;
Lancet Oncol; 2021 Apr; 22(4):558-570. PubMed ID: 33794209
[TBL] [Abstract][Full Text] [Related]
11. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
[TBL] [Abstract][Full Text] [Related]
12. Comparison of renin-angiotensin-aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes.
Bezabih YM; Bezabih A; Alamneh E; Peterson GM; Bezabhe W
BMC Infect Dis; 2021 Jun; 21(1):527. PubMed ID: 34090358
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptor blockade is associated with increased risk of giant cell arteritis.
Zhao SS; Lyu H; Zeng C; Lei G; Wei J; Mackie SL
Rheumatology (Oxford); 2023 Jun; 62(6):2203-2210. PubMed ID: 36255257
[TBL] [Abstract][Full Text] [Related]
14. Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.
Mancia G; Rea F; Ludergnani M; Apolone G; Corrao G
N Engl J Med; 2020 Jun; 382(25):2431-2440. PubMed ID: 32356627
[TBL] [Abstract][Full Text] [Related]
15. Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan.
Huang SH; Hsu CN; Yu SH; Cham TM
BMC Public Health; 2012 May; 12():288. PubMed ID: 22521158
[TBL] [Abstract][Full Text] [Related]
16. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
Trifirò G; Massari M; Da Cas R; Menniti Ippolito F; Sultana J; Crisafulli S; Giorgi Rossi P; Marino M; Zorzi M; Bovo E; Leoni O; Ludergnani M; Spila Alegiani S;
Drug Saf; 2020 Dec; 43(12):1297-1308. PubMed ID: 32852721
[TBL] [Abstract][Full Text] [Related]
17. Renin-Angiotensin-Aldosterone System Inhibitors and Development of Gynecologic Cancers: A 23 Million Individual Population-Based Study.
Nguyen NTH; Nguyen PA; Huang CW; Wang CH; Lin MC; Hsu MH; Bao HB; Chien SC; Yang HC
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835224
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
Semenzato L; Botton J; Drouin J; Baricault B; Vabre C; Cuenot F; Penso L; Herlemont P; Sbidian E; Weill A; Dray-Spira R; Zureik M
Hypertension; 2021 Mar; 77(3):833-842. PubMed ID: 33423528
[TBL] [Abstract][Full Text] [Related]
19. Preadmission use of renin-angiotensin blockers and rupture of abdominal aortic aneurysm: a nationwide, population-based study.
Wemmelund H; Høgh A; Hundborg HH; Johnsen SP; Lindholt JS
Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):141-50. PubMed ID: 26817783
[TBL] [Abstract][Full Text] [Related]
20. Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for Hypertension.
Graham DJ; Izurieta HS; Muthuri SG; Zhang D; Sandhu AT; Lu Y; Zhao Y; Feng Y; Eworuke E; Lyu H; Gandotra C; Smith ER; Avagyan A; Wernecke M; Kelman JA; Forshee RA; MaCurdy TE
J Gen Intern Med; 2021 Dec; 36(12):3802-3809. PubMed ID: 34599472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
